Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

26 Jun 2008 07:00

RNS Number : 5670X
4imprint Group PLC
26 June 2008
 

4imprint Group plc

Pre-close period trading Update

4imprint Group plc today announces a trading update for the first half of 2008, prior to the announcement of its interim results on 7 August 2008. 

Group sales, after a slower start than expected, have progressed well, and will be ahead of the comparable period in the prior year.

In the Direct Marketing Division, the growth rate of sales in the first quarter was lower than in previous years, both from prospecting investments and from our established customer base. However, the second quarter was marked by a stronger performance and sales growth returned to more normal levels, with a substantial improvement in prospecting yields.

Sales in the End User Division have shown good progress throughout the first half with both the Premiums business and Kreyer being particularly strong.

Trade Division sales in the first quarter were lower than prior year, aggravated by customer service issues in the Product Source business. Substantial efforts to eliminate these difficulties proved successful and sales improved significantly during the second quarter.

Enquiries: 

 

4imprint Group plc 

K.J. Minton, Executive Chairman

Gillian Davies, Finance Director

020 7299 7201

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFELLLVQBZBBQ
Date   Source Headline
16th Oct 201711:13 amRNSEBT purchase
9th Oct 20172:25 pmRNSEBT purchase
22nd Sep 20172:12 pmRNSEBT Purchase
20th Sep 20174:06 pmRNSHolding(s) in Company
13th Sep 20173:24 pmRNSHolding(s) in Company
17th Aug 20178:59 amRNSHolding(s) in Company
3rd Aug 20179:06 amRNSDirector/PDMR Shareholding
1st Aug 20174:41 pmRNSSecond Price Monitoring Extn
1st Aug 20174:35 pmRNSPrice Monitoring Extension
1st Aug 20177:00 amRNSHalf-year Report
4th Jul 20172:58 pmRNSHolding(s) in Company
28th Jun 201710:18 amRNSHolding(s) in Company
22nd Jun 20173:11 pmRNSHolding(s) in Company
20th Jun 20179:29 amRNSNotice of Results
16th May 20179:30 amRNSHolding(s) in Company
11th May 20172:57 pmRNSEBT Purchase
11th May 20178:38 amRNSDirector/PDMR Shareholding
10th May 20174:30 pmRNSDirector/PDMR Shareholding
10th May 20172:25 pmRNSHolding(s) in Company
10th May 201712:06 pmRNSResult of AGM
9th May 20174:02 pmRNSHolding(s) in Company
9th May 20177:00 amRNSAGM Trading Statement
8th May 20179:38 amRNSHolding(s) in Company
4th Apr 20173:52 pmRNSAnnual Financial Report
30th Mar 20179:12 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSFinal Results
19th Jan 20177:00 amRNSTrading Update and Notice of Final Results
9th Dec 20164:35 pmRNSPrice Monitoring Extension
8th Dec 20164:12 pmRNSEBT Purchase
28th Nov 201612:01 pmRNSEBT Purchase
22nd Nov 201611:03 amRNSEBT Purchase
9th Nov 201612:07 pmRNSSecond Price Monitoring Extn
9th Nov 201612:02 pmRNSPrice Monitoring Extension
2nd Nov 20167:00 amRNSTrading Update
7th Oct 20169:27 amRNSHolding(s) in Company
3rd Oct 20168:43 amRNSHolding(s) in Company
12th Aug 20168:53 amRNSHolding(s) in Company
11th Aug 20167:00 amRNSDirectorate Change
10th Aug 201611:10 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSHalf-year Report
16th Jun 20169:26 amRNSNotice of Results
19th May 20169:46 amRNSHolding(s) in Company
10th May 20164:39 pmRNSResult of AGM
10th May 201611:00 amRNSAGM Statement
9th May 201610:15 amRNSHolding(s) in Company
5th May 20168:33 amRNSHolding(s) in Company
3rd May 20168:38 amRNSTotal Voting Rights
25th Apr 20161:13 pmRNSHolding(s) in Company
19th Apr 201610:00 amRNSDirector/PDMR Shareholding
14th Apr 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.